PER
Click for more information
1.41% 7.0¢ percheron therapeutics limited

Sarepta gene therapy study missed key target in Duchennes, page-121

  1. Rod_
    718 Posts.
    lightbulb Created with Sketch. 141
    clock Created with Sketch.
    15/01/21
    18:12
    Post #: 50205600
    In terms of any gene therapy treatment regarding DMD, this is an interesting article:
    http://drugbaron.com/why-sareptas-most-recent-failure-in-dmd-was-entirely-predictable/

    And ANP is the only company with a treatment targeting the inflammation side of DMD, with a very encouraging phase 2 trial completed
    ANP Price at posting: 21.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 21  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LML Lincoln repositions Kookaburra for low-cost graphite delivery
right-arrow Created with Sketch.
TG1 TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
right-arrow Created with Sketch.
STX Strike reports flow test success at 100% owned Walyering-7
right-arrow Created with Sketch.
GML Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
right-arrow Created with Sketch.
CPV ClearVue shares up 15% as it inks deal to enter Middle East and Indian construction markets
right-arrow Created with Sketch.
AVH Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.0¢ 		Change
-0.001(1.41%) 		Mkt cap ! $63.10M
Open High Low Value Volume
7.1¢ 7.1¢ 6.9¢ $34.01K 486.5K

Buyers (Bids)

No. Vol. Price($)
2 132919 6.9¢
 

Sellers (Offers)

Price($) Vol. No.
7.3¢ 78000 1
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.